Polyphase wireless power transfer system achieves 270-kilowatt charge, s...
The U.S. Departments of Energy and Defense teamed up to create a series of weld filler materials that could dramatically improve high-strength steel repair in vehicles, bridges and pipelines.
The Earth System Grid Federation, a multi-agency initiative that gathers and distributes data for top-tier projections of the Earth’s climate, is preparing a series of upgrades.
ORNL researchers used the nation’s fastest supercomputer to map the molecular vibrations of an important but little-studied uranium compound produced during the nuclear fuel cycle for results that could lead to a cleaner, safer world.
Surrounded by the mountains of landlocked Tennessee, Oak Ridge National Laboratory’s Teri O’Meara is focused on understanding the future of the vitally important ecosystems lining the nation’s coasts.
Cement trucks entering and exiting the Spallation Neutron Source are a common sight as construction of the VENUS neutron imaging beamline progresses. Slated for completion and commissioning in 2024-2025, VENUS is the twentieth neutron instrument at SNS and will offer many new capabilities.
A new version of the Energy Exascale Earth System Model, or E3SM, is two times faster than an earlier version released in 2018.
Energy Secretary Jennifer Granholm visited ORNL on Nov. 22 for a two-hour tour, meeting top scientists and engineers as they highlighted projects and world-leading capabilities that address some of the country’s most complex research and technical challenges.
A team led by the U.S. Department of Energy’s Oak Ridge National Laboratory demonstrated the viability of a “quantum entanglement witness” capable of proving the presence of entanglement between magnetic particles, or spins, in a quantum material.
As rising global temperatures alter ecosystems worldwide, the need to accurately simulate complex environmental processes under evolving conditions is more urgent than ever.
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.